For Researchers

Neuroimaging signatures of frailty: A population-based study in community-dwelling older adults (the Atahualpa Project)

O.H.Del Brutto,.R.M. Mera, K. Cagino, et al.

Geriatr Gerontol Int. 2017;17(2):270-276

The present study identifies neuroimaging signatures in older adults interviewed with the Edmonton Frail Scale (EFS).
According to interaction models, prefrail or frail individuals aged ≥67 years presented more prominent neuroimaging signatures of diffuse cortical or subcortical damage than their robust counterparts.

 

Nonpharmacological interventions to treat physical frailty and sarcopenia in older patients: a systematic overview - the SENATOR Project ONTOP Series

I. Lozano-Montoya, A. Correa-Pérez, I. Abraha, et al.

Clin Interv Aging. 2017;12:721-740

This overview of systematic reviews highlights the importance of exercise interventions with or without nutritional supplementation to improve the physical performance in community-dwelling patients aged >65 years with physical frailty and sarcopenia. Muscle strength was improved with multidisciplinary treatment and exercise interventions in this population.

 

What is the duration of life expectancy in the state of frailty? Estimates in the SIPAF study

M. Herr, J.J. Arvieu, J. Ankri, et al.

Eur J Ageing. 2017;15(2):165-173

This study aimed to estimate the time spent in the state of frailty in men and women using the Sullivan method.

In conclusion, frailty is a transition state that is relatively limited in time compared to pre-frailty that may represent a larger time window for prevention.  

The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action

O. Ethgen, C. Beaudart, F. Buckinx, et al.

Calcif Tissue Int. 2017;100(3):229-234

This article showed that the number of sarcopenic patients will dramatically increase in the next 30 years, making consequences of muscle wasting a major public health issue.

Measurement of muscle mass in sarcopenia: from imaging to biochemical markers

M. Tosato, E. Marzetti, M. Cesari, et al.

Aging Clin Exp Res Epub 2017 Feb 10

CLICK HERE TO READ THE FULL TEXT

The aim of this article is to critically review available methods for muscle mass estimation, highlighting strengths and weaknesses of each of them as well as their proposed field of application.

Sarcopenia: an overview

E. Marzetti, R. Calvani, M. Tosato, et al.

Aging Clin Exp Res Epub 2017 Feb 10

CLICK HERE TO READ THE FULL TEXT

The “Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies” project (the SPRINTT project) has operationalized a specific condition, named physical frailty and sarcopenia (PF&S), characterized by the combination of low physical performance (based on the Short Physical Performance Battery) and low muscle mass (according to the FNIH cut-points). A randomized controlled trial will be conducted to evaluate the efficacy of a multi-component intervention for preventing mobility disability and other adverse health outcomes in older adults with PF&S.

Pages